Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine.

× No keyword cloud information.

15 in total

1. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.

Authors: Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Ami E Iskandrian; Jeffrey A Leppo; Brent Blackburn; John J Mahmarian
Journal: J Am Coll Cardiol Date: 2005-11-09 Impact factor: 24.094

Review 2. Adenosine receptors as therapeutic targets.

Authors: Kenneth A Jacobson; Zhan-Guo Gao
Journal: Nat Rev Drug Discov Date: 2006-03 Impact factor: 84.694

Review 3. N-acetylcysteine: multiple clinical applications.

Authors: Paul J Millea
Journal: Am Fam Physician Date: 2009-08-01 Impact factor: 3.292

4. Transition-state stabilization by adenosine deaminase: 1,6-addition of water to purine ribonucleoside, the enzyme's affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site.

Authors: W Jones; L C Kurz; R Wolfenden
Journal: Biochemistry Date: 1989-02-07 Impact factor: 3.162

5. Adenosine and adenosine receptors: Newer therapeutic perspective.

Authors: S Manjunath; Pranavkumar M Sakhare
Journal: Indian J Pharmacol Date: 2009-06 Impact factor: 1.200

Review 6. Regadenoson: a new myocardial stress agent.

Authors: Wael Al Jaroudi; Ami E Iskandrian
Journal: J Am Coll Cardiol Date: 2009-09-22 Impact factor: 24.094

7. Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease.

Authors: Eliana Reyes; Chee Y Loong; Kshama Wechalekar; Katherine Latus; Constantinos Anagnostopoulos; S Richard Underwood
Journal: J Nucl Cardiol Date: 2007-10-18 Impact factor: 5.952

Review 8. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases.

Authors: G Vass; I Horváth
Journal: Curr Med Chem Date: 2008 Impact factor: 4.530

9. The safety and tolerability of adenosine in patients with obstructive airways disease.

Authors: William J van Gaal; B Couthino; M Chan; K C Allman
Journal: Int J Cardiol Date: 2007-07-25 Impact factor: 4.164

10. Regadenoson.

Authors: Karly P Garnock-Jones; Monique P Curran
Journal: Am J Cardiovasc Drugs Date: 2010 Impact factor: 3.571

6 in total

Review 1. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors: Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal: J Nucl Cardiol Date: 2015-05-15 Impact factor: 5.952

Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine.

1. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.

Review 2. Adenosine receptors as therapeutic targets.

Review 3. N-acetylcysteine: multiple clinical applications.

4. Transition-state stabilization by adenosine deaminase: 1,6-addition of water to purine ribonucleoside, the enzyme's affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site.

5. Adenosine and adenosine receptors: Newer therapeutic perspective.

Review 6. Regadenoson: a new myocardial stress agent.

7. Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease.

Review 8. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases.

9. The safety and tolerability of adenosine in patients with obstructive airways disease.

10. Regadenoson.

Review 1. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

2. Regadenoson-induced complete heart block and asystole: A real possibility nuclear laboratories should be aware of.

3. Regadenoson for myocardial perfusion imaging: Is it safe?

4. Adverse effects associated with regadenoson myocardial perfusion imaging.

5. Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.

6. Asystole following regadenoson infusion in stable outpatients.